In a filing, PMV Pharmaceuticals Inc revealed its 10% Owner ORBIMED ADVISORS LLC unloaded Company’s shares for reported $0.9 million on Sep 10 ’25. In the deal valued at $1.80 per share,500,000 shares were sold. As a result of this transaction, ORBIMED ADVISORS LLC now holds 5,975,291 shares worth roughly $6.81 million.
Then, OrbiMed Private Investments V, bought 2,283,654 shares, generating $3,653,846 in total proceeds.
Before that, Ticktin Robert sold 23,151 shares. PMV Pharmaceuticals Inc shares valued at $24,651 were divested by the General Counsel & COO at a price of $1.06 per share. As a result of the transaction, Ticktin Robert now holds 98,695 shares, worth roughly $0.11 million.
Oppenheimer upgraded its PMV Pharmaceuticals Inc [PMVP] rating to an Outperform from a a Perform in a research note published recently. A number of analysts have revised their coverage, including Craig Hallum’s analysts, who began to cover the stock in mid May with a ‘”a Buy”‘ rating. Jefferies began covering PMVP with “Buy” recommendation on April 12, 2024. Ladenburg Thalmann started covering the stock on December 27, 2023. It rated PMVP as “a Buy”.
Price Performance Review of PMVP
On Monday, PMV Pharmaceuticals Inc [NASDAQ:PMVP] saw its stock fall -7.32% to $1.14. Over the last five days, the stock has lost -18.57%. PMV Pharmaceuticals Inc shares have fallen nearly -24.50% since the year began. Nevertheless, the stocks have fallen -24.50% over the past one year.
How much short interest is there in PMV Pharmaceuticals Inc?
A steep rise in short interest was recorded in PMV Pharmaceuticals Inc stocks on 2025-08-29, dropping by 13978.0 shares to a total of 0.81 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-31 was 0.82 million shares. There was a decline of -1.73%, which implies that there is a negative sentiment for the stock.
